OUTCOME OF POOR RESPONDERS AT 6 WEEKS OF INDUCTION THERAPY: JLSG-02 PROTOCOL STUDY FOR MULTISYSTEM LANGERHANS CELL HISTIOCYTOSIS IN JAPAN

被引：0
|
作者：
Kudo, Kazuko
Morimoto, Akira
Imamura, Toshihiko
Shioda, Yoko
Sato, Takashi
Ishii, Eiichi
Horibe, Keizo
Kinugawa, Naoko
Tsunematsu, Yukiko
Imashuku, Shinsaku
机构：
来源：
PEDIATRIC BLOOD & CANCER | 2011年 / 56卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：695 / 695
页数：1
相关论文
共 29 条
  • [1] ANALYSIS OF PERMANENT CONSEQUENCES IN PEDIATRIC PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS: DATA OF THE JLSG-96 AND JLSG-02 STUDIES IN JAPAN
    Shioda, Yoko
    Morimoto, Akira
    Imamura, Toshihiko
    Kudo, Kazuko
    Imashuku, Shinsaku
    [J]. PEDIATRIC BLOOD & CANCER, 2014, 61 (11) : 2140 - 2140
  • [2] INTENSIFIED AND PROLONGED THERAPY DID NOT IMPROVE THE OUTCOME IN LANGERHANS CELL HISTIOCYTOSIS WITH SINGLE-SYSTEM MULTIFOCAL BONE LESIONS; RESULTS OF JLSG-02 PROTOCOL STUDY
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Kudo, Kazuko
    Ishii, Eiichi
    Horibe, Keizo
    Bessho, Fumio
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S133 - S134
  • [3] Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan
    Shioda, Yoko
    Adachi, Souichi
    Imashuku, Shinsaku
    Kudo, Kazuko
    Imamura, Toshihiko
    Morimoto, Akira
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (06) : 545 - 551
  • [4] Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan
    Yoko Shioda
    Souichi Adachi
    Shinsaku Imashuku
    Kazuko Kudo
    Toshihiko Imamura
    Akira Morimoto
    [J]. International Journal of Hematology, 2011, 94 : 545 - 551
  • [5] Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Akira Morimoto
    Yoko Shioda
    Toshihiko Imamura
    Kazuko Kudo
    Hiroshi Kawaguchi
    Kazuo Sakashita
    Masahiro Yasui
    Yuhki Koga
    Ryoji Kobayashi
    Eiichi Ishii
    Junichiro Fujimoto
    Keizo Horibe
    Fumio Bessho
    Yukiko Tsunematsu
    Shinsaku Imashuku
    [J]. International Journal of Hematology, 2016, 104 : 99 - 109
  • [6] Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Kudo, Kazuko
    Kawaguchi, Hiroshi
    Sakashita, Kazuo
    Yasui, Masahiro
    Koga, Yuhki
    Kobayashi, Ryoji
    Ishii, Eiichi
    Fujimoto, Junichiro
    Horibe, Keizo
    Bessho, Fumio
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 104 (01) : 99 - 109
  • [7] Therapy prolongation improves outcome in multisystem Langerhans cell histiocytosis
    Gadner, Helmut
    Minkov, Milen
    Grois, Nicole
    Poetschger, Ulrike
    Thiem, Elfriede
    Arico, Maurizio
    Astigarraga, Itziar
    Braier, Jorge
    Donadieu, Jean
    Henter, Jan-Inge
    Janka-Schaub, Gritta
    McClain, Kenneth L.
    Weitzman, Sheila
    Windebank, Kevin
    Ladisch, Stephan
    [J]. BLOOD, 2013, 121 (25) : 5006 - 5014
  • [8] Relapses of multisystem/multifocal bone Langerhans cell histiocytosis in paediatric patients: Data analysis from the JLSG-96/02 study
    Sakamoto, Kenichi
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Imashuku, Shinsaku
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (06) : 769 - 775
  • [9] Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Akira Morimoto
    Yoko Shioda
    Toshihiko Imamura
    Kazuko Kudo
    Toshiyuki Kitoh
    Hiroshi Kawaguchi
    Hiroaki Goto
    Yoshiyuki Kosaka
    Yukiko Tsunematsu
    Shinsaku Imashuku
    [J]. International Journal of Hematology, 2018, 108 : 192 - 198
  • [10] Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study
    Morimoto, Akira
    Shioda, Yoko
    Imamura, Toshihiko
    Kudo, Kazuko
    Kitoh, Toshiyuki
    Kawaguchi, Hiroshi
    Goto, Hiroaki
    Kosaka, Yoshiyuki
    Tsunematsu, Yukiko
    Imashuku, Shinsaku
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 108 (02) : 192 - 198
123